Body dysmorphic disorder: A guide for dermatologists and cosmetic surgeons

被引:60
|
作者
Phillips K.A. [1 ,3 ]
Dufresne R.G. [2 ]
机构
[1] Butler Hospital, Dept. of Psychiat. and Hum. Behavior, Brown University School of Medicine, Providence, RI
[2] Department of Dermatology, Brown University School of Medicine, Providence, RI
[3] Butler Hospital, Providence, RI 02906
关键词
Fluvoxamine; Clomipramine; Body Dysmorphic Disorder; Compulsive Behavior; Hypochondriasis;
D O I
10.2165/00128071-200001040-00005
中图分类号
学科分类号
摘要
Patients with body dysmorphic disorder (BDD) often present to dermatologists and cosmetic surgeons. BDD is a relatively common yet underrecognized disorder that consists of a distressing or impairing preoccupation with an imagined or slight defect in appearance. Although any body area can be the focus of concern, preoccupation with the appearance of the skin, hair, and nose are most common. Typical associated behaviors include skin picking, mirror checking, and camouflaging (e.g., with a hat or makeup). Reassurance seeking is another common behavior that may be enacted with surgeons and dermatologists. BDD is associated with marked impairment in functioning, notably poor quality of life, and a high suicide attempt rate. The disorder appears relatively common in dermatologic and cosmetic surgery settings; in fact, dermatologists may be the type of practitioner most often consulted by patients with BDD. Psychoeducation is an important element in the treatment of BDD. For patients who compulsively pick at their skin, it is generally ineffective to simply advise them to stop picking. Educating them that the picking is a symptom of BDD, and is treatable, can be helpful. For skin pickers, a combination of psychiatric and dermatologic treatment may be best. It is probably best to avoid cosmetic procedures. Although definitive data on the treatment outcome of surgery and dermatologic treatment for BDD are lacking, and although no one can predict how a given patient will respond to such treatment, available data suggest that these treatments are unlikely to be successful and may even make the patient's condition worse. Rather than referring the patient to another dermatologist or cosmetic surgeon, we recommend attempting to refer the patient to a psychiatrist for cognitive-behavioral therapy or pharmacotherapy. Available data indicate that serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors are often effective for BDD. In recent years, BDD has gone from being a neglected psychiatric disorder to one that is becoming better recognized and understood. Nonetheless, research on this disorder is still in its early stages, and much more investigation of BDD is needed, especially in surgical and dermatologic settings. Treatment recommendations will be modified in the future as more research is done. In the meantime, it is important that dermatologists and surgeons screen patients for BDD and accurately diagnose this condition, as available psychiatric treatments are very promising for patients with this distressing and sometimes disabling disorder.
引用
收藏
页码:235 / 243
页数:8
相关论文
共 50 条
  • [41] Gazing rituals in body dysmorphic disorder
    Moellmann, Anne
    Hunger, Antje
    Schulz, Claudia
    Wilhelm, Sabine
    Buhlmann, Ulrike
    JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY, 2020, 68
  • [42] Intolerance of uncertainty in body dysmorphic disorder
    Summers, Berta J.
    Matheny, Natalie L.
    Sarawgi, Shivali
    Cougle, Jesse R.
    BODY IMAGE, 2016, 16 : 45 - 53
  • [43] Executive function in body dysmorphic disorder
    Dunai, J.
    Labuschagne, I.
    Castle, D. J.
    Kyrios, M.
    Rossell, S. L.
    PSYCHOLOGICAL MEDICINE, 2010, 40 (09) : 1541 - 1548
  • [44] Body dysmorphic disorder: history and curiosities
    França K.
    Roccia M.G.
    Castillo D.
    AlHarbi M.
    Tchernev G.
    Chokoeva A.
    Lotti T.
    Fioranelli M.
    Wiener Medizinische Wochenschrift, 2017, 167 (Suppl 1) : 5 - 7
  • [45] Pharmacological Treatment of Body Dysmorphic Disorder
    Hong, Kevin
    Nezgovorova, Vera
    Uzunova, Genoveva
    Schlussel, Danya
    Hollander, Eric
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (08) : 697 - 702
  • [46] Cognitive therapy in body dysmorphic disorder
    Ritter, Viktoria
    Stangier, Ulrich
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2013, 42 (03): : 192 - 200
  • [47] Neuropsychological performance in body dysmorphic disorder
    Hanes, KR
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 1998, 4 (02) : 167 - 171
  • [48] Quality of life in body dysmorphic disorder
    IsHak, Waguih William
    Bolton, Michael A.
    Bensoussan, Jean-Charles
    Dous, GeorgeV.
    Nguyen, Trang T.
    Powell-Hicks, Allycin L.
    Gardner, Jennifer E.
    Ponton, Kimberly M.
    CNS SPECTRUMS, 2012, 17 (04) : 167 - 175
  • [49] Pharmacologic treatment of body dysmorphic disorder
    Phillips, KA
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (04) : 597 - 605
  • [50] Experiential avoidance in body dysmorphic disorder
    Wilson, Anne C.
    Wilhelm, Sabine
    Hartmann, Andrea S.
    BODY IMAGE, 2014, 11 (04) : 380 - 383